raziel therapeutics
Series CRehovot, IsraelOct 2019
raziel therapeutics raised €20M in a Series C round in Oct 2019. The company is based in Rehovot, Israel. Investors in the round: Pontifax Funds. Data as of Nov 2026.
Amount raised
€20M
€20,203,875
Native amount
22,000,000 USD
Stage
Series C
series c
Investors
1
Provenance & confidence
Low confidenceAmount
22,000,000 USD
ECB-at-date → €20M · rate 1.0889 on 2019-09-30
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Other rounds
same companyThis is the company's only recorded round.